Clinical Trials
55 trialsRopidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
St. Jude Children's Research Hospital
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
CAMPERR
Adela, Inc
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
Children's Oncology Group
DETERMINE
Cancer Research UK
AYAConnect
UNC Lineberger Comprehensive Cancer Center
EARN
Washington University School of Medicine
Physical Activity and Quality of Life in Childhood Cancersurvivors- a Long-term Follow-up
Region Skane
EPICkids
Columbia University
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
MOM
Inova Health Care Services
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Cedars-Sinai Medical Center
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Dana-Farber Cancer Institute
ROOT
Taproot Health
SUPATEEN
Martin-Luther-Universität Halle-Wittenberg
A Pilot RCT of the PRISM Intervention for AYAs With Cancer
Seattle Children's Hospital
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
Medical University of Vienna
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
National Institutes of Health Clinical Center (CC)
PBT
Aga Khan University
IMPACT
Children's Hospital Medical Center, Cincinnati
Medical Treatment Decision Making Using Adaptive Conjoint Analysis
St. Jude Children's Research Hospital
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Northwestern University
Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer
M.D. Anderson Cancer Center
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
National Institutes of Health Clinical Center (CC)
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Celgene
Early Life Exposures in Agriculture
National Institutes of Health Clinical Center (CC)
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Acrotech Biopharma Inc.
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133
Chinese PLA General Hospital
A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers
University of Michigan Rogel Cancer Center
N1
CureOne
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer
Albert Einstein College of Medicine
Pharmacokinetic Studies Participation Survey
National Institutes of Health Clinical Center (CC)
Informed Consent in Pediatric Cancer Trials
National Institutes of Health Clinical Center (CC)
Learning Impairments Among Survivors of Childhood Cancer
St. Jude Children's Research Hospital
RTA 744 Injection in Patients With Leptomeningeal Disease
M.D. Anderson Cancer Center
B-Receptor Signaling in Cardiomyopathy
Stanford University
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
Children's Oncology Group
The Good Patient Study
St. Jude Children's Research Hospital
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
University of Minnesota
Computerized Intervention for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors
St. Jude Children's Research Hospital
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
University of South Florida
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
BCX-1777 in Treating Patients With Refractory Cancer
National Cancer Institute (NCI)
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Novartis
TRICCS
Duke University
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
National Institutes of Health Clinical Center (CC)